We have shown that the bldD gene of Streptomyces coelicolor, while required for antibiotic production and morphological differentiation, is not essential for viability. We have also demonstrated that BldD forms a higher order complex both in solution and when bound to target DNA. Purified BldD exists in three forms in solution, as a tetramer, dimer and monomer, but only in the dimeric form when bound to its own promoter/operator.
Introduction
The life cycle of the ¢lamentous bacterium Streptomyces coelicolor involves a series of metabolically and structurally distinct states. The life cycle begins with germination of a spore and the growth of a mat of vegetative, substrate mycelium that later undergoes both physiological di¡er-entiation to an antibiotic-producing state, and morphological di¡erentiation to erect spore-forming, aerial hyphae. Antibiotic production in the substrate mycelium and the formation of aerial hyphae coincide during colony development and this, together with the existence of mutations that block both of these developmental processes, suggests that they share regulatory elements. Among the so-called bld (for 'bald', lacking aerial hyphae) mutants with pleiotropic defects in both antibiotic production and morphological di¡erentiation is the single, known bldD mutant [1] . On minimal medium containing glucose as carbon source, the bldD53 mutant produces none of the four well-characterized antibiotics known to be produced by S. coelicolor, and the colonies have a fragmented surface lacking aerial structures. As is the case for many of the bld mutants, the morphological defect, but not the loss of antibiotic production, is overcome by growth on minimal medium containing mannitol as carbon source.
The bldD gene encodes a 167 amino acid protein with a deduced molecular mass of 18 167 Da. The only known mutant allele has an ACG point mutation changing a tyrosine residue at amino acid 62 to a cysteine [2] . The biochemical role for BldD has been addressed using electrophoretic mobility shift assays in which puri¢ed BldD was shown to be a DNA binding protein capable of binding its own promoter/operator, as well as the promoter/ operators of several key developmental genes [3] , including the sporulation-speci¢c sigma factor, c WhiG [4] , and the extracytoplasmic function sigma factor, c BldN [5] . Independent studies showed that a promoter/operator fragment from the S. coelicolor sigH gene, encoding the stress response sigma factor, c H [6] , could also be retarded in electrophoretic mobility shift assays using extracts from a bldD þ but not a bldD 3 strain, and BldD was later shown to be the sigH promoter binding factor. The use of DNase I footprinting analysis to delimit the DNA binding site for some of the BldD target genes suggested the imperfect inverted repeat, AGTgA (n) m TCACc, as the consensus sequence for BldD binding [3] , and the location of the binding site, together with a comparison of the putative bldD target gene transcript levels in the wild-type and bldD mutant strains, were consistent with BldD functioning as a repressor during vegetative growth. How BldD repression of its various target genes might be relieved during development is currently unknown. To gain a further understanding of how BldD exerts its regulatory e¡ects, we have constructed a chromosomal deletion of the bldD open reading frame (ORF) in S. coelicolor M600, and we have begun to address how BldD binds to its target DNAs.
Materials and methods

Bacterial strains, plasmids and culture conditions
The strains used in this work are listed in Table 1 . The plasmids used in this work are listed in Table 2 . For routine purposes, Escherichia coli strains were grown in Luria^Bertani (LB) medium at 37 ‡C and S. coelicolor was grown at 30 ‡C on R2YE agar [7] . Ampicillin (Sigma), apralan (50% apramycin (wt/wt), Provel), and spectinomycin (Sigma) were all used at 100 Wg ml 31 , and kanamycin (Sigma) and chloramphenicol (Sigma) were used at 50 and 25 Wg ml 31 , respectively.
Construction of a bldD null mutant
To construct the bldD null mutant, the REDIRECT z technology was employed according to the directions of the supplier (Bertolt Gust; Plant Bioscience Ltd., Norwich, UK, see [8] ) using the provided E. coli strains and plasmids. Brie£y, a disruption cassette containing oriT and the aac(3)IV gene conferring apramycin resistance was generated by polymerase chain reaction (PCR) using a gel-puri¢ed, 1.4 kb EcoRI^HindIII, aac(3)IV+oriT fragment from pIJ773 as template and the oligonucleotide primers CGA17 (5P-CAGCCTGCCGCGTCGACACCT TGTCCGGGGAGCCATATGATTCCGGGGATCCGT-CGACC) and CGA16 (5P-ACCCCGGCGGCACGTT TCTGCTGAGGTGGTGGGGGCTCATGTAGGCTGG-AGCTGCTTC), both of which have 39 nucleotide extensions (underlined) speci¢c for the sequences extending upstream and downstream of the ATG start and TGA stop codons of the bldD ORF, respectively. The linear, PCRampli¢ed disruption cassette was then introduced by electroporation into E. coli BW25113 containing the bldD cosmid, SC9C5 (provided by H. Kieser, John Innes Centre), and a second plasmid, pIJ790, with the V RED functions that allowed high frequency recombination between the linear disruption fragment and the SC9C5 cosmid. The disrupted cosmid was passaged through E. coli ET12567 [9] to generate unmethylated cosmid DNA, and the presence of oriT in the disruption cassette then allowed the use of conjugation [7] to introduce the PCR-targeted SC9C5 cosmid into S. coelicolor M600 for the selection of disruption mutants. Despite the presence of at least 16 kb of £anking DNA on both sides of the disrupted bldD gene, none of the resulting exconjugants had the apramycin R , kanamycin S phenotype expected for double crossover mutants. Therefore, spores isolated after non-selective growth of two of the apramycin R (apr R ), kanamycin R (kan R ) colonies that would have arisen by single crossover into the chromosome were plated (V2200 colony-forming units (CFU) from each, V100 per plate) on R2YE agar [7] in the absence of selection. After 5 days of incubation, 0.3% and 0.5% of the colonies resulting from non-selective growth of apr R /kan R colony #1 and colony #2, respectively, displayed a phenotype identical to that of the known bldD point mutant strain (S. coelicolor 1169) and were found to be apramycin R , kanamycin S . Chromosomal DNA from one candidate bald colony derived from each of the apr R /kan R colonies was digested with SphI and XmnI and subjected to Southern analysis with either a gel-puri¢ed, 32 P random primer-labeled, 1.3 kb SphIX mnI bldD fragment (isolated from pAU181 [2] ), or a gel-puri¢ed, 32 P random primer-labeled, 1.4 kb EcoRIĤ indIII aac(3)IV fragment (isolated from pIJ773) as probe.
BldD overexpression and puri¢cation
BldD was overexpressed as an amino-terminal His 6 fu- 
Bertolt Gust; Plant Bioscience Ltd., Norwich, UK, see [8] ET12567 F 3 , dam-13: :Tn9, dcm-6, hsdM, hsdR, recF143, zjj-202 : :Tn10, galK2, galT22, ara14, lacY1, xyl-5, leuB6, thi-1, tonA31, rspL136, hisG4, tsx78, mtl-1, glnV44
recA1, supE44, endA1, hsdR17, gyrA96, relA1, thiv(lac-proAB) [17] sion protein as previously described [10] . The His 6 -tagged BldD was initially puri¢ed using nickel a⁄nity chromatography [10] and then subjected to a further round of puri¢cation by ion exchange chromatography. The nickel af¢nity-puri¢ed His 6 -tagged BldD protein was applied to a Pharmacia Mono Q HR 5/5 ion exchange column equilibrated with 20 mM Tris^HCl (pH 8.5) and then eluted with a linear gradient of 0^0.5 M NaCl. The BldD-containing fractions were then analyzed by sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) and BldD was judged to be s 99% pure (not shown).
The BldD-containing fractions were pooled, dialyzed against 20 mM Tris^HCl (pH 8.5), and then applied to a Pharmacia Superose 12 HR 10.30 gel ¢ltration column that had been equilibrated in the same bu¡er. The elution pro¢le of BldD was then compared to the pro¢le of protein standards (bovine serum albumin (66 kDa), L-lactamase (29.5 kDa) and cytochrome c (12 kDa)) run under the same conditions. BldD with an amino-terminal glutathione S transferase (GST) tag was overexpressed as previously described [3] . The soluble protein fraction was puri¢ed by a⁄nity chromatography using glutathione agarose (Sigma) [3] . The column was washed with 1Uphosphate bu¡ered saline (PBS) and the protein was eluted with reduced glutathione (10 mM, Sigma). The purity of the GST-BldD fusion protein was assessed by SDS^PAGE analysis of aliquots from each fraction. In order to concentrate the protein and to replace the column bu¡er with 20 mM Tris^HCl (pH 8.5) bu¡er containing 150 mM NaCl, those fractions judged to be s 99% pure after Coomassie staining were subjected to centrifugation in an Ultrafree 0 -4 Centrifugal Filter (Millipore).
Electrophoretic mobility shift assay
Electrophoretic mobility shift assays were performed using the 77 bp MAE16-4 probe fragment spanning nucleotides 3 31^þ40 of the bldD promoter as described previously [10] . 0^40 pmol of His 6 -BldD and/or GST-BldD and 1^2 ng (20^40 fmol) of end-labeled MAE16-4 probe were added to each 20 Wl reaction, and after incubation at 30 ‡C the bound and free DNA products were separated on a 1.5% glycerol-containing, 8% polyacrylamide gel. Gels were dried and exposed to a phosphor screen before analysis using a phosphorimager (Molecular Dynamics model 445 SI).
Results and discussion
3.1. Constructed bldD null mutants have the same phenotype as the bldD point mutant
Several failed attempts to construct a bldD null mutant strain had suggested that BldD might, in addition to its known role in the regulation of antibiotic production and morphological di¡erentiation, have an essential function. To address whether the previous failure to generate a null mutant was due to an essential function being disrupted, or was due to a very low frequency in which a double crossover into the chromosome might be expected to occur with relatively short £anking sequences in the disruption cassette, we decided to use a newly developed, PCR-targeted mutagenesis system (called REDIRECT z ) [8] to generate a bldD null mutant. The REDIRECT z technology (adapted from [11] ) allows disruption of the gene of interest on the cosmid that contains the gene. The disrupted gene is then subsequently transferred to the chro- Fig. 1 . Southern analysis con¢rming bldD deletion and replacement by aac(3)IV in S. coelicolor vbldD1 and vbldD2. A is a schematic diagram of the chromosomal DNA of wild-type and disrupted bldD showing the location of the SphI and XmnI sites and the sizes of the resulting digestion products. FRT = £ip recombinase target, aac(3)IV = apramycin resistance gene, oriT = origin of transfer. Thicker lines indicate £anking chromosomal DNA. 1^2 Wg of total DNA were digested with SphI and XmnI, separated on a 1% agarose gel, transferred to nylon membrane (Amersham) and hybridized with either (B) a gel-puri¢ed, random primer-labeled, 1.3 kb SphI^XmnI bldD fragment (isolated from pAU181 [2] ), or (C) a gel-puri¢ed, random primer-labeled, 1.4 kb EcoRI^HindIII aac(3)IV fragment (isolated from pIJ773). The sizes of PstI-digested V molecular mass marker bands are shown on the left. mosome by a homologous recombination step in which the large (usually several kilobases) £anking sequences on the cosmid increase the likelihood of crossover into the chromosome.
Using REDIRECT z , apramycin R , kanamycin S colonies with a phenotype identical to that of the known bldD point mutant strain were isolated after introduction of the disrupted bldD cosmid into S. coelicolor M600. Two of these apparent double crossover exconjugants were con¢rmed by Southern analysis to have the bldD coding region replaced by the disruption cassette ( Fig. 1 ) and designated S. coelicolor vbldD1 and S. coelicolor vbldD2. Hybridization to the expected 1.3 kb SphI^XmnI bldD fragment in the parent M600 strain is seen in Fig. 1B . Deletion in S. coelicolor strains vbldD1 and vbldD2 of the bldD ORF and replacement with the aac(3)IV-containing disruption cassette resulted in the expected introduction of an XmnI site and the release of two fragments (951 bp and 1262 bp; see Fig. 1A ) that would hybridize to the bldD £anking regions on the 1.3 kb bldD probe (Fig.  1B) . Hybridization of the same two fragments to the aac-(3)IV probe (Fig. 1C ) and failure to detect any aac(3)IV- Fig. 2 . Phenotype of the constructed bldD null mutant strains. A shows wild-type S. coelicolor strain 916 and its congenic bldD point mutant 1169 grown for 3 days at 30 ‡C on R2YE agar. B shows S. coelicolor M600 and the bldD null mutant strains, vbldD1 and vbldD2, grown under the same conditions. C shows restoration in vbldD1 and vbldD2 of wild-type levels of antibiotic production and sporulation after introduction by conjugation of the PC31 att site-integrating plasmid, pSET6bldD. Strains containing pSET6bldD, or pSET6 as a negative control, were grown on R2YE agar plates containing spectinomycin (100 Wg ml 31 ) for 3 days at 30 ‡C.
hybridizing fragments in the wild-type M600 strain con¢rmed the deletion of bldD and replacement with the aac-(3)IV-containing disruption cassette. As is the case for the known point mutant strain ( Fig. 2A) , both null mutants were unable to sporulate and produced red pigment when grown on the rich R2YE medium (Fig. 2B ) and sporulation was restored on minimal medium containing mannitol as carbon source (not shown). Since bldD has been shown to be monocistronic [2] , deletion of the bldD ORF and replacement with an antibiotic resistance marker was not expected to have polar e¡ects. Despite this, a bldD complementing plasmid was constructed to con¢rm that the phenotypic changes were due to deletion of bldD. The plasmid, designated pSET6bldD, was a derivative of pSET6 (gift from J. Nodwell; [12] ) in which a 1.3 kb, EcoRI^XbaI bldD fragment from pAU181 [2] had been inserted into the EcoRI and XbaI sites in the multiple cloning site. While introduction of the parent vector, pSET6, had no e¡ect on the phenotype of the bldD null mutant strains, introduction of pSET6bldD caused the expected restoration of wild-type levels of antibiotic production and sporulation (Fig. 2C ).
BldD exists mainly as a dimer in solution and as a dimer when bound to its own promoter
Since we had previously predicted that BldD binds to an inverted repeat sequence in its own promoter/operator region [10] , it seemed reasonable to suggest that it might bind DNA in a dimeric form with one monomer interacting with each half site. To address this possibility, the oligomeric state of BldD was examined both in solution and when bound to a fragment of DNA encompassing the known BldD binding site [3] in its own promoter/operator region.
In order to determine the oligomeric state in solution, BldD was overexpressed as an amino-terminal His 6 fusion protein [10] and puri¢ed as described in Section 2. BldD judged to be s 99% pure was then subjected to size exclusion chromatography and its elution pro¢le was compared to the pro¢le of protein standards run under the same conditions (Fig. 3) . BldD eluted in three peaks which, by comparison to the elution pro¢les of the standards, were believed to correspond to tetrameric, dimeric and monomeric forms of the protein. In two separate gel ¢ltration experiments, most of the BldD protein was in the dimer form, as has been found for many transcription factors (reviewed in [13] ), and estimation of the areas under the peaks allowed us to determine that the ratio of tetramer :dimer :monomer was approximately 2:7:1. Very recently, gel ¢ltration chromatography also suggested that BldB, a small transcription factor that appears to regulate its own synthesis [14] , dimerizes in solution [15] . In order to determine the oligomeric state of BldD when bound to DNA, an electrophoretic mobility shift assay was conducted in which both the His 6 -BldD (described above), as well as GST-BldD (see Section 2), were employed. Electrophoretic mobility shift assays were performed using the 77 bp MAE16-4 probe [10] . As had been seen previously for the His 6 -BldD [10] , two shifted bands were observed both in the presence of His 6 -BldD and GST-BldD (Fig. 4) . Since the GST-BldD was signi¢-cantly larger than the His 6 -BldD, the GST-BldD proteinbound DNA was less mobile in the gel. When equal amounts of the two fusion proteins were mixed together and incubated with the end-labeled probe, the two bands corresponding to the GST-BldD-bound DNA, and the two bands corresponding to the His 6 -BldD-bound DNA were seen. In addition, a protein-bound fragment of intermediate mobility was also observed. Although our ¢ndings suggest that BldD exists primarily as a dimer in solution and that it is also in the dimeric form once bound to DNA, we cannot conclude with certainty that it is the dimer form of BldD that makes initial contact with its target DNA. The presence of a small fraction of the monomer in solution leaves open the possibility that BldD binding in vivo occurs via the monomer pathway [16] in which two monomers could bind sequentially to each of the half sites and then assemble their dimerization interface when bound to the DNA. Although use of the monomer pathway has been shown to increase the speci¢city of protein:DNA complex formation [16] , it seems unlikely that BldD follows the monomer pathway for binding to its target promoters since no binding was observed when the left half site fragment of the bldD promoter/operator was separated from the right half site and used as a probe in gel mobility shift experiments [10] .
